









Markets
/
Stocks
/
nasdaq-gmed
/

Globus Medical Inc

GMED

87.170USD

+0.920+1.07%

Market hours （ET）Quotes delayed by 15 min

20.60BMarket Cap

21.91P/E TTM



Globus Medical Inc

87.170

+0.920+1.07%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Globus Medical Inc

Currency: USD Updated: 2026-03-25

Key Insights

Globus Medical Inc's fundamentals are relatively very healthy, with industry-average ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 17 out of 209 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 106.00.In the medium term, the stock price is expected to remain stable.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Globus Medical Inc's Score

Industry at a Glance

Industry Ranking

17 / 209

Overall Ranking

90 / 4547

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

Globus Medical Inc Highlights

StrengthsRisks

Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions with a focus on improving the quality of life of patients with musculoskeletal disorders. The Company offers a portfolio of differentiated technologies that are used to treat a variety of musculoskeletal conditions. Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures. Its spine products address the conditions affecting the spine, including degenerative conditions, deformities, tumors, and trauma. It provides solutions that facilitate both open and minimally invasive surgery techniques. It includes traditional fusion implants, such as pedicle screws and rod systems, and others. Its orthopedic trauma solutions are designed to treat a variety of orthopedic fracture patterns and patient anatomies in the upper and lower extremities, as well as the hip.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 87.37% year-on-year.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 2.94B.

Undervalued

The company’s latest PE is 21.96, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 118.97M shares, decreasing 8.37% quarter-over-quarter.

Held by CI Select Canadian Equity Fund

Star Investor CI Select Canadian Equity Fund holds 855.00 shares of this stock.

Analyst Rating

Based on 16 analysts

Buy

Current Rating

106.000

Target Price

+21.55%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-03-25

The current financial score of Globus Medical Inc is 8.93, ranking 11 out of 209 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 826.42M, representing a year-over-year increase of 25.73%, while its net profit experienced a year-over-year increase of 430.44%.

Score

Industry at a Glance

Previous score

8.93

Change



Financials

10.00

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

8.76

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

9.06

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

9.29

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.55

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Globus Medical Inc's Company Valuation

Currency: USD Updated: 2026-03-25

The current valuation score of Globus Medical Inc is 7.35, ranking 93 out of 209 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 21.96, which is 1552.00% below the recent high of 362.76 and 9.92% above the recent low of 19.78.

Score

Industry at a Glance

Previous score

7.35

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 17/209

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-03-25

The current earnings forecast score of Globus Medical Inc is 7.63, ranking 126 out of 209 in the Healthcare Equipment & Supplies industry. The average price target is 92.00, with a high of 114.00 and a low of 76.00.

Score

Industry at a Glance

Previous score

7.63

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 16 analysts

Buy

Current Rating

106.000

Target Price

+21.55%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

115

Total

Median

Average

Company name

Ratings

Analysts

Globus Medical Inc

GMED

Medtronic PLC

MDT

Stryker Corp

SYK

Abbott Laboratories

ABT

Dexcom Inc

DXCM

Zimmer Biomet Holdings Inc

ZBH

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-03-25

The current price momentum score of Globus Medical Inc is 6.92, ranking 73 out of 209 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 95.37 and the support level at 81.84, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.80

Change

0.12

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(2)

Buy(3)

Indicators

Value

Direction

MACD(12,26,9)

-0.046

Sell

RSI(14)

47.144

Neutral

STOCH(KDJ)(9,3,3)

61.953

Buy

ATR(14)

2.377

Low Volatility

CCI(14)

35.932

Neutral

Williams %R

27.818

Buy

TRIX(12,20)

-0.228

Sell

StochRSI(14)

100.000

Buy

Moving Average

Sell(3)

Neutral(0)

Buy(3)

Indicators

Value

Direction

MA5

86.674

Buy

MA10

86.315

Buy

MA20

88.465

Sell

MA50

89.855

Sell

MA100

87.282

Sell

MA200

72.816

Buy

Institutional Confidence

Currency: USD Updated: 2026-03-25

The current institutional shareholding score of Globus Medical Inc is 10.00, ranking 1 out of 209 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 106.78%, representing a quarter-over-quarter increase of 2.08%. The largest institutional shareholder is The Vanguard, holding a total of 10.52M shares, representing 9.33% of shares outstanding, with 3.21% decrease in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

The Vanguard Group, Inc.

Star Investors

10.58M

-0.97%

BlackRock Institutional Trust Company, N.A.

9.67M

-1.41%

Janus Henderson Investors

7.55M

-7.97%

State Street Investment Management (US)

3.46M

-0.34%

Burgundy Asset Management Ltd.

3.46M

-0.59%

Sculptor Capital Management, Inc

3.50M

+26.78%

JP Morgan Asset Management

3.44M

+8.93%

Madison Avenue Partners LP

2.55M

+48.83%

Risk Assessment

Currency: USD Updated: 2026-03-25

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Globus Medical Inc is 5.73, ranking 75 out of 209 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.09. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. Globus Medical Inc’s latest ESG disclosure is at an average level in the Healthcare Equipment & Supplies industry, showing no material impact on overall risk.